Jea Yu, Contributing Author at MarketBeat Articles by Jea Yu - Page 30January 30, 2024 5:10 AM ETHumana EPS shocker. Are Medicare Advantage plans in jeopardy? Jea YuHumana shares are falling after the health insurance carrier reported a bombshell when it cut its 2024 and 2025 earnings guidanceNYSE:HUMNYSE:UNHNYSE:CVSRead Humana EPS shocker. Are Medicare Advantage plans in jeopardy? January 30, 2024 4:25 AM ETIs Adient’s guidance cut a positive sign for the auto suppliers?Jea YuAdient stock is rallying as the company's bad news was better than feared, and the company expects to improve sales and margins in fiscal 2024NYSE:ADNTNYSE:GMNYSE:FRead Is Adient’s guidance cut a positive sign for the auto suppliers?January 30, 2024 4:15 AM ETAmerican Superconductor faster than a speeding bullet on EPS beatJea YuMegawatt-scale power resiliency solutions provider American Superconductor Co. shares surged 40% on its Q3 2023 earnings report, and there may be more upsideNASDAQ:AMSCNASDAQ:POWIOTCMKTS:SMEGFRead American Superconductor faster than a speeding bullet on EPS beatJanuary 29, 2024 4:31 AM ETCould Rumble’s video platform reach its tipping point in 2024? Jea YuVideo-sharing platform Rumble shares surged over 60% in a week, driven by a number of catalysts and is catching the attention of traders and investorsNASDAQ:RUMNASDAQ:DWACNASDAQ:AMZNRead Could Rumble’s video platform reach its tipping point in 2024? January 29, 2024 4:25 AM ET2 undisputed chip leaders that each owns a 90% market share Jea YuThese two chip stocks have 90% or more market share in their respective markets, and these companies are still hungry for growthNASDAQ:ASMLNASDAQ:NVDANYSE:TSMRead 2 undisputed chip leaders that each owns a 90% market share January 29, 2024 4:15 AM ETMarriott International is the juggernaut that keeps growingJea YuMarriott International stock continues to make new all-time highs as the travel boom continues to rebound and may have further room to runNASDAQ:MARNYSE:HLTLON:IHGRead Marriott International is the juggernaut that keeps growingJanuary 25, 2024 6:18 AM ETHow to use the Greeks for your options tradingJea YuWhether you’re new to or are experienced with stock options trading, you’ll always be exposed to the Greeks on any stock that has options NASDAQ:AMDRead How to use the Greeks for your options tradingJanuary 23, 2024 6:23 AM ET2 gene editing stocks to keep on your 2024 watchlistJea YuGene therapy is receiving much of the spotlight in the medical sector in 2024. The FDA approval for Casgevy, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX)NASDAQ:BEEMWNASDAQ:BEEMNASDAQ:VRTXRead 2 gene editing stocks to keep on your 2024 watchlistJanuary 23, 2024 6:00 AM ET2 IoT stocks staging a 2024 tipping-point year Jea YuThe Internet of Things (IoT) is a network of physical machines, devices, or "things" outfitted with sensors, applications, and connectivity, enabling them NASDAQ:PINYSE:IOTNASDAQ:CSCORead 2 IoT stocks staging a 2024 tipping-point year January 23, 2024 5:30 AM ETCeragon is the under-the-radar networking stock you should knowJea YuCeragon Networks Ltd. (NASDAQ: CRNT) is a provider of high-performance wireless infrastructure solutions to cellular operators and wireless service providers. NASDAQ:CRNTNYSE:NOKNASDAQ:CSCORead Ceragon is the under-the-radar networking stock you should knowJanuary 23, 2024 5:30 AM ETIs iRobot entering value territory at these levels? Jea YuAmazon.com Inc. (NASDAQ: AMZN) announced its buyout of iRobot Co. (NASDAQ: IRBT) for $1.7 billion in an all-cash transaction for $61 per share in August 2022. NASDAQ:IRBTNASDAQ:AMZNRead Is iRobot entering value territory at these levels? January 23, 2024 5:25 AM ETWhich stock is a one-stop shop for outdoor lifestyles?Jea YuOutdoor products and lifestyle manufacturer Vista Outdoor Inc. (NASDAQ: VSTO) may not be a familiar name, but its portfolio of brands is. NYSE:VSTONYSE:DKSOTC:CZGZFRead Which stock is a one-stop shop for outdoor lifestyles?January 23, 2024 5:21 AM ETSarepta Therapeutics Inc.: Why it's a rising gene therapy starJea YuSarepta Therapeutics Inc. (NASDAQ: SRPT) is a leading commercial-stage biotech focused on developing precision gene therapy treatments for rare diseases. NASDAQ:SRPTNYSE:PFENASDAQ:WVERead Sarepta Therapeutics Inc.: Why it's a rising gene therapy starJanuary 23, 2024 4:18 AM ETThe Coty turnaround can accelerate in 2024Jea YuGlobal beauty products maker Coty Inc. has been in a turnaround that looks to accelerate in 2024 as the company rides the medicated beauty trendNYSE:COTYNYSE:ELNYSE:ELFRead The Coty turnaround can accelerate in 2024January 23, 2024 4:12 AM ETCould CAVA Group be the Chipotle of Mediterranean food?Jea YuMediterranean fast-casual restaurant operator CAVA Group Inc. (NASDAQ: CAVA) is often compared to Chipotle Mexican Grill Inc. (NYSE: CMG), as customers also NYSE:CAVANYSE:CMGNYSE:SGRead Could CAVA Group be the Chipotle of Mediterranean food?January 22, 2024 5:39 AM ETIs Applied Digital’s 35% stock plunge an AI buying opportunity?Jea YuApplied Digital Co. (NASDAQ: APLD) shares experienced a 4X surge in 2023, riding the artificial intelligence (AI) trend as a provider of next-generation AI NASDAQ:APLDNYSE:HPENASDAQ:EQIXRead Is Applied Digital’s 35% stock plunge an AI buying opportunity?January 17, 2024 5:00 AM ETMedtronic receives FDA approval for deep brain stimulation systemJea YuMedical device maker Medtronic PLC (NYSE: MDT) received U.S. FDA approval for its implantable medical device called the Percept PC Deep Brain Stimulation (DBS) NYSE:MDTNYSE:ABTRead Medtronic receives FDA approval for deep brain stimulation systemJanuary 17, 2024 5:00 AM ETSolo Brands cooked on 2023 guidance cut. Is it a bargain or trap? Jea YuOutdoor and lifestyle products maker Solo Brands Inc. (NASDAQ: DTC) has grown a cult like following under its many brands. This consumer discretionary sector NYSE:DTCNYSE:DKSNYSE:VSTORead Solo Brands cooked on 2023 guidance cut. Is it a bargain or trap? January 16, 2024 7:00 AM ETTime to buy these 3 healthcare companies that raised revenue guidance?Jea YuThe new year brings a clean slate heading into the fourth-quarter earnings season. Check out a few companies that have raised revenue guidance.NASDAQ:EXASNASDAQ:HOLXNASDAQ:FOLDRead Time to buy these 3 healthcare companies that raised revenue guidance?January 16, 2024 5:48 AM ETSurgery Partners feeling no pinch from macroeconomic weaknessJea YuSurgery Partners Inc. (NASDAQ: SGRY) is a leading healthcare services provider that owns and operates over 180 outpatient surgical centers in 31 states. NASDAQ:SGRYNYSE:HCARead Surgery Partners feeling no pinch from macroeconomic weaknessJanuary 16, 2024 5:43 AM ETZIM Shipping stock proves unsinkable despite Red Sea disruptionsJea YuThe Houthi attacks on cargo ships in the Red Sea have caused widespread disruptions and economic ramifications for the transportation sector with cargo NYSE:ZIMNASDAQ:TSLANYSE:NMMRead ZIM Shipping stock proves unsinkable despite Red Sea disruptionsJanuary 16, 2024 5:00 AM ETQuantumScape surges on solid-state EV battery: Hype or home run? Jea YuQuantumScape Co. (NYSE: QS) has been developing the next-generation solid-state lithium-metal batteries for electric vehicles (EV). Learn more.NYSE:QSNYSE:FOTCMKTS:VWAGYRead QuantumScape surges on solid-state EV battery: Hype or home run? January 16, 2024 5:00 AM ET 2 biotechs with promising weight-loss drugs comingJea YuClinical weight-loss medications have been making headlines as GLP-1 drugs like Novo Nordisk A/S (NYSE: NVO) owned Ozempic and Wegovy and Eli Lilly and Co.NASDAQ:VKTXNASDAQ:RYTMNYSE:LLYRead 2 biotechs with promising weight-loss drugs comingJanuary 16, 2024 5:00 AM ETAffordable networking stocks to watch on the Juniper buyoutJea YuNetwork communications equipment provider Juniper Networks Inc. (NASDAQ: JNPR) is being acquired by Hewlett Packard Enterprise Co. (NYSE: HPE) for NASDAQ:EXTRNASDAQ:INFNNYSE:JNPRRead Affordable networking stocks to watch on the Juniper buyout Page 30 of 89 « Most Recent‹ More Recent27282930313233 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
